Mitigating Human Error and Supporting Compliance with Smart Technology

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology Quality and Regulatory Sourcebook March 2023
Volume 2023 eBook
Issue 2
Pages: 18–22

Technological advances hold promise for mitigating human error in the pharmaceutical industry, especially in quality assurance/quality control, by reducing the incidence of, and risk associated with, mistakes.

Standard quality control. Certification. Business, technology, internet and networking concept | Image Credit: © PHOTON_PHOTO - STOCK.ADOBE.COM

PHOTON_PHOTO - STOCK.ADOBE.COM

Facing new global challenges, pharmaceutical company leaders are looking to prioritize operational strategies to remain competitive in this rapidly evolving business environment. Recent events that range from the COVID-19 pandemic to new regulatory guidelines to economic inflation have required pharma manufacturers to find new ways to streamline workflows and minimize risks. Disruptions caused by the pandemic and related restrictions continue to impact supply chains and logistics worldwide. Additionally, many companies have shifted toward remote and hybrid working, and have increased their use of digital technologies to maintain business continuity and protect the health of employees.

These changes are accelerating the need for new innovations. One solution is the use of intelligent informatics in the pharmaceutical quality control (QC) laboratory to improve the quality and safety of drugs and reduce the risk of costly errors and recalls. However, while technology can simplify many workflows, it also comes with a learning curve and new burdens may be placed on its users. Pharma companies must determine the effectiveness of technological advancements and the potential challenges they may introduce in an environment like pharmaceutical quality assurance/quality control (QA/QC).

Read this article in Pharmaceutical Technology's March 2023 Quality and Regulatory Sourcebook eBook.

About the author

Mike Wilson, QA/QC Strategy, Waters Corporation

Article details

Pharmaceutical Technology
eBook: Quality and Regulatory Sourcebook
March 2023
Pages: 18–22

Citation

When referring to this article, please cite it as Wilson, M. Mitigating Human Error and Supporting Compliance with Smart Technology. Pharmaceutical Technology's Quality and Regulatory Sourcebook eBook (March 2023)

Articles in this issue
Standard quality control. Certification. Business, technology, internet and networking concept | Image Credit: © PHOTON_PHOTO - STOCK.ADOBE.COM
Mitigating Human Error and Supporting Compliance with Smart Technology
Murrstock - Stock.adobe.com
Phase-appropriate Analytical Methodology
How Banning Titanium Dioxide Might Impact Pharma
How Banning Titanium Dioxide Might Impact Pharma
Pharmacovigilance Automation
Pharmacovigilance Automation
Making compound. Image Credit: ©tyyang - tyyang - Stock.adobe.com
Quality Considerations for the Manufacture of Compounded Drugs
AI, Machine learning, Hands of robot and human touching big data of Global network connection, Internet and digital technology, Science and artificial Image Credit: ©ipopba ipopba - Stock.adobe.com
Overcoming Data Gaps in Pharmacovigilance
relif - Stock.adobe.com
Points to Consider for Knowledge Management Acceleration
Recent Videos
CPHI Milan 2024: Compliance and Automation in Aseptic Processing
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Creates CDER Center for Real-World Evidence Innovation

Susan Haigney
December 13th 2024
Article

The Center for Drug Evaluation and Research’s new center will coordinate and promote use of real-word data in regulatory decisions.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Novo Nordisk Gains Manufacturing Sites from Novo Holdings and Novavax while EC Approves Catalent Acquisition

Feliza Mirasol
December 11th 2024
Article

The European Commission has approved Novo Holdings' acquisition of Catalent, which includes the related sale of three manufacturing sites to Novo Nordisk, which is also acquiring the Czech Republic manufacturing site of Novavax for $200 million.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Releases Guidance on Accelerated Approvals

Susan Haigney
December 6th 2024
Article

The draft guidance provides information on the agency’s accelerated approval process and criteria for approval.

3d rendering. Empty blank black metal sphere balance scale on white background. | Image Credit: ©PATARA – stock.adobe.com

Comparability in Accelerated or Stressed Stability Studies Using a Quality Range

Richard K. Burdick
December 6th 2024
Article

A statistical procedure based on a quality range is proposed for demonstrating comparability between pre-change and post-change process slopes in an accelerated or stressed stability study.